On Saturday, the US state department issued details of who qualifies for a limited waiver during the Trump administration’s 90-day pause of foreign aid. The freeze has resulted in the temporary close ...
In today’s newsletter, Mia Malan explains how US President Donald Trump ordered USAID-funded HIV organisations in SA to shut down. Sign up for our newsletter today. Pepfar-funded HIV organisations in ...
In today’s newsletter, Mia Malan explains how the twice-yearly HIV prevention jab, lenacapavir, will be rolled out with or without the US. Sign up for our newsletter today. The Global Fund for HIV, TB ...
In 2021, clinics had a 20% vacancy rate for doctor positions and 14% of doctor posts were empty in hospitals too. (Envato Elements) South Africa is producing more doctors than what the country’s under ...
In today’s newsletter, Mia Malan tells us more about how SA will roll out LEN. Sign up for our newsletter today. The health department plans to make the twice-a-year anti-HIV jab, lenacapavir, ...
In today’s newsletter, Zano Kunene looks at why the child support grant needs to be increased. Sign up. A rooster crows, waking baby Athande from her afternoon nap. She lets out a loud shriek and ...
In today’s newsletter, Mia Malan explains why Gilead Sciences and Sahpra are talking about lenacapavir. Sign up for our newsletter now. Gilead Sciences, the maker of a twice-a-year anti-HIV injection, ...
During this initiation season, we look back at what happened in 2013 when bungled initiations cost boys their penises. It was day 25 and Xhobiso Pungulwa* (18) slowly pushed himself up in his bed. He ...
In today’s newsletter, Ida Jooste and Tanya Pampalone tells us how RFK Jr is now SA’s problem too. Sign up for our newsletter today. They used to call it the strangling angel. The grey membrane would ...
In today’s newsletter, Mia Malan asks who in SA should get LEN first. Sign up for our newsletter today. One in ten clinics in South Africa — across 22 health districts in six provinces — could start ...
In today’s newsletter, our editor-in-chief Mia Malan and content editor Linda Pretorius look at what it may cost South Africa to supply HIV-prevention drug lenacapavir. Sign up for our newsletter now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results